Skip to main content

Table 4 Summary of stability studies for VEN in QC samples

From: Quantification of venadaparib, a novel PARP inhibitor, in the rat and dog plasma using liquid chromatography/tandem mass spectrometry

Batch

Theoretical concentration (ng/mL)

Rat

Dog

3

800

3

800

(A) Short-term stability at room temperature (22 °C, 22 h for rats, 24 h for dogs, n = 6)

Mean estimated concentration

2.62

725

3.15

688

RE (%)1

 − 12.7

 − 9.4

5.0

 − 14.0

CV (%)2

5.7

5.6

7.5

3.3

(B) Freezethaw stability (3 cycles for rats, 4 cycles for dogs, n = 6)

Mean estimated concentration

2.59

710

2.90

735

RE (%)

 − 13.7

 − 11.3

 − 3.5

 − 8.1

CV (%)

5.9

7.6

8.1

2.9

(C) Long-term stability (107 days for rats, 87 days for dogs, n = 6)

Mean estimated concentration

3.42

907

29.7

693

RE (%)

14.0

13.4

 − 1.0

 − 13.4

CV (%)

12.1

5.0

4.4

4.0

(D) Processed sample stability (at 10 °C for 8 days, n = 3)

Mean estimated concentration

3.00

773

3.08

785

RE (%)

0.0

 − 3.4

2.7

 − 1.9

CV (%)

2.4

4.1

0.7

1.4

  1. 1RE (%) = (calculated concentration − theoretical concentration)/theoretical concentration × 100
  2. 2CV (%) = standard deviation of the concentration/mean concentration × 100